X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (22) 22
index medicus (21) 21
pharmacology & pharmacy (21) 21
abnormal-cannabidiol (20) 20
humans (16) 16
abnormal cannabidiol (14) 14
cannabinoid receptor (10) 10
cannabinoids (10) 10
gpr18 (9) 9
male (9) 9
receptors, g-protein-coupled - metabolism (9) 9
vasodilation - drug effects (9) 9
anandamide (8) 8
arachidonic acids - pharmacology (8) 8
gpr55 (8) 8
receptors, cannabinoid - metabolism (8) 8
lipids (7) 7
mesenteric vasodilation (7) 7
n-arachidonoyl glycine (7) 7
rats (7) 7
resorcinols - pharmacology (7) 7
article (6) 6
cannabinoid (6) 6
cyclohexanes - pharmacology (6) 6
ligands (6) 6
piperidines - pharmacology (6) 6
pyrazoles - pharmacology (6) 6
abnormal cannabidiol receptor (5) 5
anisoles - pharmacology (5) 5
cannabidiol (5) 5
cannabidiol - pharmacology (5) 5
cannabinoid receptors (5) 5
dose-response relationship, drug (5) 5
endothelium (5) 5
glycine - analogs & derivatives (5) 5
in-vivo (5) 5
mitogen-activated protein kinase 1 - metabolism (5) 5
mitogen-activated protein kinase 3 - metabolism (5) 5
nagly (5) 5
protein-coupled receptor (5) 5
rats, wistar (5) 5
receptors, g-protein-coupled - agonists (5) 5
receptors, g-protein-coupled - genetics (5) 5
small mesenteric-artery (5) 5
brain (4) 4
cannabinoids - metabolism (4) 4
cb2 receptors (4) 4
cellular migration (4) 4
channels (4) 4
endothelial-cells (4) 4
glycine - pharmacology (4) 4
in vitro techniques (4) 4
nitric oxide (4) 4
o-1918 (4) 4
pharmacology (4) 4
rat (4) 4
receptor, cannabinoid, cb1 - metabolism (4) 4
activation (3) 3
anandamide-induced vasorelaxation (3) 3
blood pressure - drug effects (3) 3
blood vessels (3) 3
cannabinoid receptor agonists (3) 3
cannabinoids - pharmacology (3) 3
capsaicin - analogs & derivatives (3) 3
capsaicin - pharmacology (3) 3
cells, cultured (3) 3
dilatation (3) 3
endocannabinoid (3) 3
endocannabinoids (3) 3
endocannabinoids - metabolism (3) 3
endometriosis (3) 3
endothelium, vascular - drug effects (3) 3
expression (3) 3
fatty acids (3) 3
female (3) 3
glaucoma (3) 3
glycine (3) 3
identification (3) 3
intraocular-pressure (3) 3
mesenteric arteries - drug effects (3) 3
mice (3) 3
microglia (3) 3
microglial cell-migration (3) 3
muscle, smooth, vascular - drug effects (3) 3
neurosciences (3) 3
ng-nitroarginine methyl ester - pharmacology (3) 3
nitric-oxide (3) 3
phenols (3) 3
phosphorylation (3) 3
physiological aspects (3) 3
polyunsaturated alkamides - pharmacology (3) 3
potassium channels (3) 3
proteins (3) 3
pulmonary artery - drug effects (3) 3
rat model (3) 3
receptor, cannabinoid, cb2 - metabolism (3) 3
receptors, cannabinoid - drug effects (3) 3
receptors, cannabinoid - genetics (3) 3
research (3) 3
research papers (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 02/2018, Volume 820, pp. 256 - 264
Chronic GPR18 activation by its agonist abnormal cannabidiol (trans-4-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; abn-cbd)... 
Diabetes | Abnormal cannabidiol | O-1918 | GPR-18 | Cardiac dysfunction | Adiponectin | OXIDATIVE STRESS | MESENTERIC-ARTERIES | BLOOD-PRESSURE | CONSCIOUS RATS | CANNABINOID RECEPTOR | ROSTRAL VENTROLATERAL MEDULLA | FEMALE RATS | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | ENDOCANNABINOID RECEPTOR GPR18 | ADIPOSE-TISSUE | Diabetes Mellitus, Experimental - drug therapy | Rats, Wistar | Male | Cardiotonic Agents - therapeutic use | Diabetes Mellitus, Experimental - blood | Receptors, Cannabinoid - metabolism | Resorcinols - pharmacology | Myocardium - metabolism | Nitric Oxide Synthase Type III - metabolism | Phosphorylation - drug effects | Diabetes Mellitus, Experimental - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Diabetes Mellitus, Experimental - physiopathology | Nitric Oxide - blood | Rats | Cardiotonic Agents - pharmacology | Resorcinols - therapeutic use | Adiponectin - blood | Gene Expression Regulation - drug effects | Animals | Ventricular Dysfunction, Left - drug therapy | Mitogen-Activated Protein Kinase 3 - metabolism | Hemodynamics - drug effects | Oxidative Stress - drug effects | Blood Glucose - metabolism | Mitogen-Activated Protein Kinase 1 - metabolism | Heart | Medical colleges | Hyperglycemia | Nitric oxide | Diabetes therapy | Index Medicus | adiponectin | cardiac dysfunction | diabetes | abnormal cannabidiol
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 2016, Volume 94, pp. 179 - 195
Abstract Pharmacological manipulation of the endocannabinoid system represents a promising therapy to alleviate L-3,4-dihydroxyphenylalanine (L-DOPA)-induced... 
Neurology | AIMs | NF-κB | CB1 | COX-2 | pAcH3 | LID | TRPV-1 | Neuroinflammation | ERK 1/2 | Cannabinoid | PPAR gamma | Anandamide | NITRIC-OXIDE SYNTHASE | PROLIFERATOR-ACTIVATED RECEPTORS | GAMMA PPAR-GAMMA | ABNORMAL INVOLUNTARY MOVEMENTS | NEUROSCIENCES | MESSENGER-RNA LEVELS | RAT MODEL | NF-kappa B | LEVODOPA-INDUCED DYSKINESIA | NF-KAPPA-B | CANNABINOID RECEPTOR AGONIST | PARKINSONS-DISEASE | Endocannabinoids - metabolism | Tyrosine 3-Monooxygenase - metabolism | Dyskinesia, Drug-Induced - physiopathology | Anti-Dyskinesia Agents - toxicity | Capsaicin - pharmacology | Male | NF-kappa B - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Oxidopamine | PPAR gamma - metabolism | TRPV Cation Channels - metabolism | Arachidonic Acids - metabolism | Dyskinesia, Drug-Induced - drug therapy | Parkinsonian Disorders - drug therapy | Parkinsonian Disorders - physiopathology | Mice, Inbred C57BL | Cannabidiol - pharmacology | Capsaicin - analogs & derivatives | Levodopa - toxicity | Dyskinesia, Drug-Induced - pathology | Polyunsaturated Alkamides - metabolism | Brain - drug effects | Receptor, Cannabinoid, CB1 - metabolism | Anti-Dyskinesia Agents - pharmacology | Animals | Parkinsonian Disorders - pathology | Cyclooxygenase 2 - metabolism | Brain - pathology | Histones - metabolism | Physiological aspects | Phenols | COX-2 inhibitors | Fatty acids | Movement disorders
Journal Article
Journal of Labelled Compounds and Radiopharmaceuticals, ISSN 0362-4803, 04/2011, Volume 54, Issue 4, pp. 180 - 184
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 03/2004, Volume 487, Issue 1-3, pp. 213 - 221
Journal Article
Journal of Inflammation (United Kingdom), ISSN 1476-9255, 07/2016, Volume 13, Issue 1, p. 21
Journal Article
Experimental Eye Research, ISSN 0014-4835, 07/2012, Volume 100, pp. 59 - 64
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 04/2012, Volume 165, Issue 8, pp. 2414 - 2424
Journal Article
BRITISH JOURNAL OF PHARMACOLOGY, ISSN 0007-1188, 04/2003, Volume 138, Issue 7, pp. 1320 - 1332
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 11/2007, Volume 152, Issue 5, pp. 825 - 831
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2007, Volume 559, Issue 2, pp. 189 - 195
The receptor(s) used by cannabinoids to relax vascular smooth muscle is unknown. Here, we investigated the effects of 2-arachidonylglyceryl ether (2-AG ether),... 
MEK/ERK1/2 | Pertussis toxin sensitive G proteins | Cannabinoid CB 1 receptor | Abnormal cannabidiol | 2-Arachidonylglyceryl ether | Abn-CBD receptor | Cannabinoid CB | receptor | pertussis toxin sensitive G proteins | ENDOGENOUS CANNABINOIDS | ACTIVATION | ANANDAMIDE | CB1 RECEPTOR | cannabinoid CB1 receptor | SMALL MESENTERIC-ARTERY | CANNABINOID RECEPTOR | 2-arachidonylglyceryl ether | abnormal cannabidiol | IN-VIVO | PHARMACOLOGY & PHARMACY | abn-CBD receptor | BRAIN | PROTEIN-KINASE-II | AGONIST | Phosphorylation | Muscle, Smooth, Vascular - metabolism | Receptors, G-Protein-Coupled - metabolism | Dose-Response Relationship, Drug | Resorcinols - pharmacology | Pulmonary Artery - metabolism | Piperidines - pharmacology | Flavonoids - pharmacology | Myocytes, Smooth Muscle - drug effects | Receptors, G-Protein-Coupled - drug effects | Myocytes, Smooth Muscle - metabolism | Muscle, Smooth, Vascular - drug effects | Pertussis Toxin - pharmacology | Pyrazoles - pharmacology | Animals, Newborn | Rabbits | Receptor Cross-Talk | Vasodilator Agents - pharmacology | Cells, Cultured | Pulmonary Artery - drug effects | Glycerides - pharmacology | Animals | MAP Kinase Signaling System - drug effects | Mitogen-Activated Protein Kinase 3 - metabolism | Rimonabant | Receptor, Cannabinoid, CB1 - drug effects | Protein Kinase Inhibitors - pharmacology | Vasodilation - drug effects | In Vitro Techniques | Mitogen-Activated Protein Kinase 1 - metabolism
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 12/2007, Volume 152, Issue 7, pp. 1092 - 1101
Journal Article
Central Nervous System Agents in Medicinal Chemistry, ISSN 1871-5249, 2012, Volume 12, Issue 3, pp. 233 - 239
Journal Article
Handbook of Experimental Pharmacology, ISSN 0171-2004, 2005, Volume 168, Issue 168, pp. 1 - 51
Conference Proceeding